Register

COURSE DESCRIPTION: 
Please join us for a conference on Bladder Cancer Today: Molecular Insights and Therapeutic Advances with Spencer Bachow M.D. Dr. Bachow will describe the diagnosis of non–muscle-invasive, muscle-invasive, and metastatic urothelial carcinoma of the bladder, describe the pathogenesis of non–muscle-invasive, muscle-invasive, and metastatic urothelial carcinoma of the bladder and discuss evidence-based treatment approaches for muscle-invasive and metastatic urothelial carcinoma of the bladder.

TARGET AUDIENCE:
Internal Medicine Physicians, Pharmacists, Physician Assistants, Residents,  Advanced Practice Registered Nurses, and all other interested healthcare providers

LEARNING OBJECTIVES:

  • Describe the diagnosis of non–muscle-invasive, muscle-invasive, and metastatic urothelial carcinoma of the bladder.
  • Describe the pathogenesis of non–muscle-invasive, muscle-invasive, and metastatic urothelial carcinoma of the bladder.
  • Discuss evidence-based treatment approaches for muscle-invasive and metastatic urothelial carcinoma of the bladder.
     

FACULTY AND DISCLOSURES:

Spencer Bachow, M.D.
Medical oncologist and hematologist  
Baptist Health Boca Raton Regional Hospital 
Boca Raton, Florida
 

Spencer Bachow, M.D., faculty for this educational activity, is on the speakers’ bureau for Natera Inc. and has indicated that the presentation or discussion will not include off-label or unapproved product usage. This financial relationship has been mitigated.

John F. Rubin, M.D., FACP, director for this educational activity, has no relevant financial relationships with ineligible companies* to disclose, and has indicated that the presentation or discussion will not include off-label or unapproved product usage.

Non-faculty contributors and others involved in the planning, development and editing/review of the content have no relevant financial relationships with ineligible companies* to disclose.

*Ineligible companies – Companies whose primary business is producing, marketing, selling, reselling, or distributing healthcare products used by or on patients.

Disclosure Policy and Disclaimer

ACCREDITATION STATEMENTS AND CREDITS

Baptist Health South Florida is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. Baptist Health has been re-surveyed by the ACCME and awarded Commendation for 6 years as a provider of CME for physicians.

Baptist Health South Florida designates this live activity for a maximum of 1 AMA PRA Category 1 Credit™.  Physicians should claim only the credit commensurate with the extent of their participation in the activity.   

This activity has been approved for 1 credit hour, CE Broker Course #20-1296402, by the Florida Boards of Medicine, Podiatry, Osteopathic Medicine and Physician Assistants.  

This activity has also been approved for 1 credit for Nurse Practitioners, Nurses, Pharmacists and Pharmacy Techs, Laboratory Personnel, Athletic Trainers and Respiratory Techs. Baptist Health South Florida CE Broker Provider #50-182.

Session date: 
12/16/2025 - 7:30am to 8:30am EST
Location: 
Zoom
United States
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Florida Board of Athletic Training
  • 1.00 General certificate of attendance
  • 1.00 Florida Board of Dentistry
  • 1.00 Florida Board of Laboratory Personnel
  • 1.00 Nurse Practitioners
  • 1.00 Florida Board of Nursing
  • 1.00 Florida Board of Occupational Therapy
  • 1.00 Florida Board of Pharmacy
  • 1.00 Florida Board of Respiratory Therapy
Please login or register for a Baptist Health CME account to take this course.